UCB, betting on seizure cell therapy, to buy Neurona for up to $1.2B: what does it mean for Market Access?
UCB Expands Into Regenerative Medicine with $1.2B Acquisition of Neurona Therapeutics Summary Belgian drug company UCB has announced its acquisition of Neurona Therapeutics for $650 million upfront, with the potential